Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials
Zhiwei Zhang1, Chenguang Wang, James F Troendle
1Division of Biostatistics, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, U.S.A.
Abstract:
Clinical trials usually collect information on a large number of variables or endpoints, including one or more primary endpoints as well as a number of secondary endpoints representing different aspects of treatment effectiveness and safety. In this article, we focus on serial testing procedures that test multiple endpoints in a pre-specified order, and consider how to optimize the order of endpoints subject to any clinical constraints, with respect to the expected number of successes (i.e., endpoints that reach statistical significance) or the expected gain (if endpoints are associated with numerical utilities). We consider some common approaches to this problem and propose two new approaches: a greedy algorithm based on conditional power and a simulated annealing algorithm that attempts to improve a given sequence in a random and iterative fashion. Simulation results indicate that the proposed algorithms are useful for finding a high-performing sequence, and that optimized fixed sequence procedures can be competitive against traditional multiple testing procedures such as Holm's. The methods and findings are illustrated with two examples concerning migraine and asthma.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
Methods of Medium Optimization
Clinical Trials
There are four phases in a clinical trial. A phase one...
Statistical Hypothesis Testing
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...